Form 4: Gilead Sciences Executive Johanna Mercier Sells Shares Under 10b5-1 Trading Plan

Chief Commercial Officer of Gilead Sciences, Johanna Mercier, sold 5,490 shares of common stock at $73.98 per share on August 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Johanna Mercier, Chief Commercial Officer of Gilead Sciences, sold 5,490 shares of Gilead Sciences (GILD) common stock on August 13, 2024.
• The sale was executed at a price of $73.98 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on April 30, 2024.
• Following the transaction, Mercier directly owns 114,979 shares of Gilead Sciences common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an executive stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Executive stock sales are a common occurrence and are often related to personal financial planning. The use of a 10b5-1 trading plan allows insiders to sell shares without being accused of trading on non-public information.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, but is unlikely to be significant given the relatively small number of shares sold compared to the total outstanding shares of Gilead Sciences.

Key Dates